These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32792992)

  • 1. Association Between Parental Anxiety and Depression Level and Psychopathological Symptoms in Offspring With 22q11.2 Deletion Syndrome.
    Sandini C; Schneider M; Eliez S; Armando M
    Front Psychiatry; 2020; 11():646. PubMed ID: 32792992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.
    Tang SX; Yi JJ; Calkins ME; Whinna DA; Kohler CG; Souders MC; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Psychol Med; 2014 Apr; 44(6):1267-77. PubMed ID: 24016317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
    Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
    Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.
    Tang SX; Yi JJ; Moore TM; Calkins ME; Kohler CG; Whinna DA; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Bilker WB; Gur RC; Gur RE
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):991-1000.e2. PubMed ID: 25151422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.
    Kates WR; Mariano MA; Antshel KM; Chandra S; Gamble H; Giordano M; MacMaster E; Mattar M; St Fleur D; Faraone SV; Fremont WP
    Psychol Med; 2019 Aug; 49(11):1914-1922. PubMed ID: 30226117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring associations between diurnal cortisol, stress, coping and psychopathology in adolescents and young adults with 22q11.2 deletion syndrome.
    Ilen L; Feller C; Eliez S; Micol E; Delavari F; Sandi C; Zanoletti O; Schneider M
    Compr Psychoneuroendocrinol; 2022 Feb; 9():100103. PubMed ID: 35755923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Armando M; Lin A; Pontillo M; Vicari S
    Psychiatry Res; 2017 Aug; 254():238-243. PubMed ID: 28477546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.
    Hooper SR; Curtiss K; Schoch K; Keshavan MS; Allen A; Shashi V
    Res Dev Disabil; 2013 May; 34(5):1758-69. PubMed ID: 23506790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for parental psychopathology: a study in families with children or adolescents with psychopathology.
    Wesseldijk LW; Dieleman GC; van Steensel FJA; Bartels M; Hudziak JJ; Lindauer RJL; Bögels SM; Middeldorp CM
    Eur Child Adolesc Psychiatry; 2018 Dec; 27(12):1575-1584. PubMed ID: 29644474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
    Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower cortisol levels and attenuated cortisol reactivity to daily-life stressors in adults with 22q11.2 deletion syndrome.
    van Duin EDA; Vaessen T; Kasanova Z; Viechtbauer W; Reininghaus U; Saalbrink P; Vingerhoets C; Hernaus D; Booij J; Swillen A; Vorstman J; van Amelsvoort T; Myin-Germeys I
    Psychoneuroendocrinology; 2019 Aug; 106():85-94. PubMed ID: 30959234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis.
    Goldenberg PC; Calkins ME; Richard J; McDonald-McGinn D; Zackai E; Mitra N; Emanuel B; Devoto M; Borgmann-Winter K; Kohler C; Conroy CG; Gur RC; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jan; 159B(1):87-93. PubMed ID: 22170773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical functional connectivity in resting-state networks of individuals with 22q11.2 deletion syndrome: associations with neurocognitive and psychiatric functioning.
    Mattiaccio LM; Coman IL; Schreiner MJ; Antshel KM; Fremont WP; Bearden CE; Kates WR
    J Neurodev Disord; 2016; 8():2. PubMed ID: 26855683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodromal and autistic symptoms in schizotypal personality disorder and 22q11.2 deletion syndrome.
    Esterberg ML; Ousley OY; Cubells JF; Walker EF
    J Abnorm Psychol; 2013 Feb; 122(1):238-49. PubMed ID: 22686870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions.
    Shashi V; Veerapandiyan A; Schoch K; Kwapil T; Keshavan M; Ip E; Hooper S
    J Intellect Disabil Res; 2012 Sep; 56(9):865-78. PubMed ID: 21883601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental ADHD and Depression: Time-Varying Prediction of Offspring Externalizing Psychopathology.
    Brammer WA; Galán CA; Mesri B; Lee SS
    J Clin Child Adolesc Psychol; 2018; 47(sup1):S137-S149. PubMed ID: 27398972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary dysmaturation affects psychopathology and neurodevelopment in 22q11.2 Deletion Syndrome.
    Sandini C; Chambaz M; Schneider M; Armando M; Zöller D; Schaer M; Sandi C; Van De Ville D; Eliez S
    Psychoneuroendocrinology; 2020 Mar; 113():104540. PubMed ID: 31958652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizotypal traits in adolescents with 22q11.2 deletion syndrome: validity, reliability and risk for psychosis.
    Fonseca-Pedrero E; Debbané M; Schneider M; Badoud D; Eliez S
    Psychol Med; 2016 Apr; 46(5):1005-13. PubMed ID: 26670707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.